GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma
Top Cited Papers
Open Access
- 28 June 2005
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 43 (6), 1007-1012
- https://doi.org/10.1016/j.jhep.2005.05.028
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humansProceedings of the National Academy of Sciences, 2005
- Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinomaJournal of Hepatology, 2004
- Comparative proteomic analysis of de‐N‐glycosylated serum from hepatitis B carriers reveals polypeptides that correlate with disease statusProteomics, 2004
- A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decadesProceedings of the National Academy of Sciences, 2002
- Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver diseaseHepatology, 2002
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- Screening for hepatocellular carcinomaHepatology, 1998
- Prospective study of α-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinomaHepatology, 1994
- Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosisJournal of Hepatology, 1994
- Basic principles of ROC analysisSeminars in Nuclear Medicine, 1978